Literature DB >> 7640139

Drugs, money and society.

T Walley1.   

Abstract

Mesh:

Year:  1995        PMID: 7640139      PMCID: PMC1365120          DOI: 10.1111/j.1365-2125.1995.tb04461.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

Review 1.  Drug utilisation review and pharmacoeconomics: interaction after parallel development?

Authors:  S Garattini; G Tognoni
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

Review 2.  Drug utilisation studies as tools in health economics.

Authors:  J A Sacristán; J Soto
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

3.  Is there a need for an independent centre for pharmacoeconomics in the UK?

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

4.  Health economics in primary care in the UK: containment of drug costs.

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

5.  Warning signals from Oregon.

Authors:  R Klein
Journal:  BMJ       Date:  1992-06-06

6.  Research and development for the National Health Service.

Authors:  M Peckham
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

7.  Clinical pharmacology and therapeutics in undergraduate medical education in the UK: current status.

Authors:  T Walley; J Bligh; M Orme; A Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

8.  Centers for education and research in therapeutics.

Authors:  R L Woosley
Journal:  Clin Pharmacol Ther       Date:  1994-03       Impact factor: 6.875

  8 in total
  6 in total

Review 1.  The value of reporting therapeutic ineffectiveness as an adverse drug reaction.

Authors:  R H Meyboom; M Lindquist; A K Flygare; C Biriell; I R Edwards
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

Review 2.  Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics.

Authors:  S Barton; T Walley
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

3.  From NCE to NICE: the role of pharmacoeconomics.

Authors:  Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

4.  Drugs, money and society (Part II).

Authors:  Tom Walley
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

5.  Public views on priority setting for high cost medications in public hospitals in Australia.

Authors:  Gisselle Gallego; Susan J Taylor; Paul McNeill; Jo-anne E Brien
Journal:  Health Expect       Date:  2007-09       Impact factor: 3.377

6.  Pharmacoeconomics: a challenge for clinical pharmacologists.

Authors:  T Walley; P Davey
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.